Effect of Shiga toxin, OMVs, and innate immune cells on epithelial integrity of human colonoids during EHEC infection
志贺毒素、OMV 和先天免疫细胞对肠出血性大肠杆菌感染期间人结肠上皮完整性的影响
基本信息
- 批准号:9978339
- 负责人:
- 金额:$ 21.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-02-21 至 2022-01-31
- 项目状态:已结题
- 来源:
- 关键词:ActinsAcuteAnimalsAntibiotic TherapyAntibioticsAntibodiesApicalApoptosisApoptoticArchitectureBacteriaBacterial InfectionsBacterial ToxinsBacteriophagesBindingBiological ModelsBlood CirculationBrush BorderCell DeathCellsCessation of lifeChildhoodCoculture TechniquesColonComplexCultured CellsCytolysisDevelopmentDiseaseDrug TargetingEnterocytesEnvironmentEpithelialEpithelial CellsEpitheliumEscherichia coli EHECEscherichia coli InfectionsEscherichia coli O157:H7EvaluationEventEvolutionExperimental ModelsFutureGlycolipidsGoalsGoblet CellsHemolytic-Uremic SyndromeHumanImmuneIndividualInfantInfectionInflammationInflammatoryIntegration Host FactorsIntestinesIntoxicationKidney DiseasesKidney FailureKnowledgeLabelLaboratoriesLeadLesionLifeMAP Kinase Kinase KinaseMeasuresMediatingMembraneMethodsModelingMovementMucous MembraneMucous body substanceMusNeuroendocrine CellOrganoidsOryctolagus cuniculusPathway interactionsPhysiologyProductionProtein Synthesis InhibitorsRiskRoleSeptic ToxemiaSerotypingShiga ToxinShiga-Like Toxin IISignal TransductionStressSupportive careSurfaceSystemSystemic diseaseTestingTight JunctionsToxinTubeType III Secretion System PathwayTyrosine Kinase InhibitorValidationVariantVesicleVirulence FactorsWorkabsorptionalpha Toxinbasebeefcell typecellular targetingdiarrheal diseasefoodborneglobotriaosylceramidegut colonizationhuman modelin vivoinflammatory disease of the intestineinsightintestinal barrierintestinal epitheliummacrophagemicrobiotamigrationmonolayerpathogenpreventreceptor expressionresponsestem cellstissue cultureuptake
项目摘要
Enterohemorrhagic E. coli (EHEC) serotype O157:H7 is a foodborne diarrheal illness typically transmitted by
contaminated beef or produce. EHEC produce Shiga toxin (Stx), a protein synthesis inhibitor that can cause
severe disease, and upon systemic absorption, can lead to the devastating illness, hemolytic uremic syndrome
(HUS). Because Stx is encoded by a lysogenic bacteriophage, antibiotic therapy is precluded, as antibiotics
may induce the phage and increase toxin production, exacerbating disease.
EHEC-mediated damage to the intestinal epithelium is critical for HUS by facilitating movement of Stx from the
intestine into the bloodstream. Upon colonizing the intestinal epithelium, EHEC penetrates the mucus layer and
injects effectors into host cells via a type 3 secretion system, triggering formation of “attaching and effacing”
(AE) lesions characterized by microvillar effacement and actin pedestal formation beneath bound bacteria.
Stxs can induce proinflammatory responses in intoxicated cells and cause cell death. It has been postulated
that EHEC disrupts intestinal barrier function when cytoskeletal rearrangements are induced by injected type 3-
secreted effectors, by Stx-mediated enterocyte death, and/or by the influx of inflammatory cells.
Unfortunately, we lack an understanding of how epithelial damage and subsequent toxin uptake occurs, in part
because we lack models that mimic the complex disease-promoting interactions that occur in vivo between
EHEC, Stx and the multiple host cell types. A recently developed 2-D colonoid model permits an evaluation of
the contributions of bacteria, host cells, and the toxin itself in uptake of Stx into intestinal cells and transfer
across the intestinal epithelium. Colonoid monolayers, derived from stem cells, polarize and differentiate into
the four cell types that comprise human colon, so cell-specific virulence factor target(s) can be distinguished,
and their apical and basolateral surfaces are accessible. Like in human colon, an apical adherent mucus layer
is present. Inflammatory cells such as macrophages can be introduced, adding to the ability to study EHEC-
colonic epithelial interactions in the presence of immune cells. The 2-D colonoid model allows for assessment
of how individual virulence factors may work in concert to cause maximal intestinal damage.
In this proposal, we identify intestinal epithelial targets of Stx and key events that promote toxin binding and
uptake. We assess how Stx2 and outer membrane vesicles (OMV’s) containing Stx2 and other EHEC
virulence factors interact with colonoid cells in the presence and absence of macrophages and EHEC. . We
test whether intoxication by Stx itself influences these interactions.. Finally, we assess the effect of Stx, OMV’s,
EHEC and/or macrophage co-culture on the apical junction complex, epithelial cell apoptosis, and
proinflammatory molecule expression. By understanding the sequential proinflammatory, intestinal epithelium-
damaging events that occur during EHEC infection that lead to systemic uptake of Stx, we hope to identify
which of these events may be critical and drug-targetable, thus preventing HUS.
Enterohehemorrhagic E. coli(EHEC)血清型O157:H7是一种通常通过
被污染的牛肉或农产品。 EHEC产生Shiga毒素(STX),这是一种可能引起的蛋白质合成抑制剂
严重的疾病以及全身虐待,可能导致造成毁灭性疾病,溶血性尿毒症综合征
(HUS)。由于STX是由溶酶因细菌噬细胞编码的,因此抗生素治疗被排除为抗生素
可能诱导噬菌体并增加毒素产生,加剧疾病。
EHEC介导的对肠上皮的损害对HUS对HUS至关重要
肠道进入血液。在定居肠上皮时,EHEC穿透了粘液层,
通过3型分泌系统注入宿主细胞,触发“连接和eSf缩”的形成
(AE)以微绒毛能和肌动蛋白基座形成为特征的病变。
STX可以诱导陶醉细胞中促炎反应并导致细胞死亡。它已经假设
当细胞骨架重排被注入3型 -
STX介导的肠细胞死亡和/或受炎症细胞的影响,分泌作用。
不幸的是,我们缺乏对上皮损害和随后的毒素摄取的理解,部分部分是
因为我们缺乏模仿体内发生的复杂促进疾病相互作用的模型
EHEC,STX和多种主机单元类型。最近开发的二维结构化模型允许评估
细菌,宿主细胞和毒素本身在摄入STX进入肠细胞的贡献并转移
跨肠上皮。源自干细胞的结肠单层,极化并分化为
包括人类结肠的四种细胞类型,因此可以区分细胞特异性病毒因子靶标,
并且可以访问它们的顶端和基底外侧表面。就像人类结肠一样,顶端粘附层
在场。可以引入炎性细胞,例如巨噬细胞,从而增加了研究EHEC-的能力
在免疫细胞存在下结肠上皮相互作用。 2-D结肠模型允许评估
关于单个病毒因素如何协同起作用,从而导致最大的肠道损伤。
在此提案中,我们确定了STX的肠上皮靶标和促进毒素结合和的关键事件
吸收。我们评估含有STX2和其他EHEC的STX2和外膜蔬菜(OMV)
在存在和不存在巨噬细胞和EHEC的情况下,毒力因子与结肠细胞相互作用。 。我们
测试STX本身是否会影响这些相互作用。最后,我们评估了STX,OMV的效果,
EHEC和/或巨噬细胞共培养物,上皮连接络合物,上皮细胞凋亡和
促炎分子表达。通过了解顺序促炎性,肠上皮
EHEC感染期间发生的破坏事件导致系统性吸收,我们希望确定
这些事件中的哪一个可能是至关重要的,可以靶向毒品,从而防止HUS。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN M LEONG其他文献
JOHN M LEONG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN M LEONG', 18)}}的其他基金
Features of PMN Senescence that Lead to Susceptibility to Pneumococcal Infection
导致肺炎球菌感染易感性的中性粒细胞衰老特征
- 批准号:
10152199 - 财政年份:2021
- 资助金额:
$ 21.24万 - 项目类别:
Features of PMN Senescence that Lead to Susceptibility to Pneumococcal Infection
导致肺炎球菌感染易感性的中性粒细胞衰老特征
- 批准号:
10356895 - 财政年份:2021
- 资助金额:
$ 21.24万 - 项目类别:
Effect of Shiga toxin, OMVs, and innate immune cells on epithelial integrity of human colonoids during EHEC infection
志贺毒素、OMV 和先天免疫细胞对肠出血性大肠杆菌感染期间人结肠上皮完整性的影响
- 批准号:
10112822 - 财政年份:2020
- 资助金额:
$ 21.24万 - 项目类别:
FASEB SRC on Molecular Pathogenesis: Mechanisms of Infectious Disease
FASEB SRC 关于分子发病机制:传染病机制
- 批准号:
8908265 - 财政年份:2015
- 资助金额:
$ 21.24万 - 项目类别:
CRASP-mediated Serum Resistance by Borrelia burgdorferi
CRASP 介导的伯氏疏螺旋体的血清耐药性
- 批准号:
8953318 - 财政年份:2015
- 资助金额:
$ 21.24万 - 项目类别:
CRASP-mediated Serum Resistance by Borrelia burgdorferi
CRASP 介导的伯氏疏螺旋体的血清耐药性
- 批准号:
9087098 - 财政年份:2015
- 资助金额:
$ 21.24万 - 项目类别:
Stx-mediated disease and immunomodulatory effectors of enterohemorrhagic E.coli
Stx介导的肠出血性大肠杆菌疾病和免疫调节效应器
- 批准号:
8570980 - 财政年份:2013
- 资助金额:
$ 21.24万 - 项目类别:
Stx-mediated disease and immunomodulatory effectors of enterohemorrhagic E.coli
Stx介导的肠出血性大肠杆菌疾病和免疫调节效应器
- 批准号:
8692645 - 财政年份:2013
- 资助金额:
$ 21.24万 - 项目类别:
EHEC-induced actin rearrangement and Stx2 translocation across epithelium
EHEC 诱导的肌动蛋白重排和 Stx2 跨上皮易位
- 批准号:
8207883 - 财政年份:2011
- 资助金额:
$ 21.24万 - 项目类别:
EHEC-induced actin rearrangement and Stx2 translocation across epithelium
EHEC 诱导的肌动蛋白重排和 Stx2 跨上皮易位
- 批准号:
8029721 - 财政年份:2011
- 资助金额:
$ 21.24万 - 项目类别:
相似国自然基金
探索在急性呼吸窘迫综合征动物模型和患者长时间俯卧位通气过程中动态滴定呼气末正压的意义
- 批准号:82270081
- 批准年份:2022
- 资助金额:76 万元
- 项目类别:面上项目
多肽纳米纤维水凝胶对灵长类动物急性脊髓损伤后脱髓鞘和再髓鞘化的保护作用及其机制
- 批准号:81972064
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
氨转运蛋白Rhcg在急性肝衰竭动物氨致脑水肿发生中的作用机制
- 批准号:
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
建立脑内急性基因编辑的孤独症非人灵长类动物模型
- 批准号:
- 批准年份:2019
- 资助金额:100 万元
- 项目类别:专项基金项目
呼气末正压与动态/静态机械能比值的相关性研究:针对不同肺损伤模型的动物实验及初步临床验证
- 批准号:81871582
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
相似海外基金
Selective actin remodeling of sensory neurons for acute pain management
感觉神经元的选择性肌动蛋白重塑用于急性疼痛管理
- 批准号:
10603436 - 财政年份:2023
- 资助金额:
$ 21.24万 - 项目类别:
Chlamydia type III effectors affecting the host actin-based cytoskeleton
III 型衣原体效应子影响宿主肌动蛋白细胞骨架
- 批准号:
10632935 - 财政年份:2023
- 资助金额:
$ 21.24万 - 项目类别:
Elucidating the role of Myosin 5b in intestinal inflammation
阐明肌球蛋白 5b 在肠道炎症中的作用
- 批准号:
10883872 - 财政年份:2023
- 资助金额:
$ 21.24万 - 项目类别:
ArpC3-mediated actin remodeling in insulin granule exocytosis and diabetes
ArpC3 介导的肌动蛋白重塑在胰岛素颗粒胞吐作用和糖尿病中的作用
- 批准号:
10583734 - 财政年份:2023
- 资助金额:
$ 21.24万 - 项目类别:
Unanticipated roles of C5aR1 Signaling Leading from Acute to Chronic Kidney Disease
C5aR1 信号转导从急性肾病到慢性肾病的意外作用
- 批准号:
10591053 - 财政年份:2023
- 资助金额:
$ 21.24万 - 项目类别: